Pimobendan prevents cardiac dysfunction, mitigates cardiac mitochondrial dysfunction, and preserves myocyte ultrastructure in a rat model of mitral regurgitation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Pimobendan prevents cardiac dysfunction, mitigates cardiac mitochondrial dysfunction, and preserves myocyte ultrastructure in a rat model of mitral regurgitation ; volume:19 ; number:1 ; day:23 ; month:8 ; year:2023 ; pages:1-14 ; date:12.2023
BMC veterinary research ; 19, Heft 1 (23.8.2023), 1-14, 12.2023
- Urheber
-
Boonpala, Pakit
Saengklub, Nakkawee
Srikam, Sirinapa
Ji-au, Wilawan
Panyasing, Yaowalak
Kumphune, Sarawut
Kijtawornrat, Anusak
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12917-023-03693-2
- URN
-
urn:nbn:de:101:1-2023110608582391438514
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Boonpala, Pakit
- Saengklub, Nakkawee
- Srikam, Sirinapa
- Ji-au, Wilawan
- Panyasing, Yaowalak
- Kumphune, Sarawut
- Kijtawornrat, Anusak
- SpringerLink (Online service)
Ähnliche Objekte (12)
Sacubitril/valsartan mitigates cardiac remodeling, systolic dysfunction, and preserves mitochondrial quality in a rat model of mitral regurgitation
Subclinical Cardiac Dysfunction in Rheumatoid Arthritis
ALDH2 mitigates LPS-induced cardiac dysfunction, inflammation, and apoptosis through the cGAS/STING pathway
Cardiac-specific overexpression of Ndufs1 ameliorates cardiac dysfunction after myocardial infarction by alleviating mitochondrial dysfunction and apoptosis
Extracorporeal life support in pediatric cardiac dysfunction
JDP2 overexpression provokes cardiac dysfunction in mice
Zyxin protects from hypertension-induced cardiac dysfunction
UCP3 Ablation Exacerbates High-Salt Induced Cardiac Hypertrophy and Cardiac Dysfunction
Inhibition of the cardiac fibroblast-enriched histone methyltransferase Dot1L prevents cardiac fibrosis and cardiac dysfunction
Caffeic acid ethanolamide prevents cardiac dysfunction through sirtuin dependent cardiac bioenergetics preservation
Lipoxin A4 improves cardiac remodeling and function in diabetes-associated cardiac dysfunction
Chronic kidney disease mediates cardiac dysfunction associated with increased resident cardiac macrophages
Sacubitril/valsartan mitigates cardiac remodeling, systolic dysfunction, and preserves mitochondrial quality in a rat model of mitral regurgitation
Subclinical Cardiac Dysfunction in Rheumatoid Arthritis
ALDH2 mitigates LPS-induced cardiac dysfunction, inflammation, and apoptosis through the cGAS/STING pathway
Cardiac-specific overexpression of Ndufs1 ameliorates cardiac dysfunction after myocardial infarction by alleviating mitochondrial dysfunction and apoptosis
Extracorporeal life support in pediatric cardiac dysfunction
JDP2 overexpression provokes cardiac dysfunction in mice
Zyxin protects from hypertension-induced cardiac dysfunction
UCP3 Ablation Exacerbates High-Salt Induced Cardiac Hypertrophy and Cardiac Dysfunction
Inhibition of the cardiac fibroblast-enriched histone methyltransferase Dot1L prevents cardiac fibrosis and cardiac dysfunction
Caffeic acid ethanolamide prevents cardiac dysfunction through sirtuin dependent cardiac bioenergetics preservation
Lipoxin A4 improves cardiac remodeling and function in diabetes-associated cardiac dysfunction
Chronic kidney disease mediates cardiac dysfunction associated with increased resident cardiac macrophages
Sacubitril/valsartan mitigates cardiac remodeling, systolic dysfunction, and preserves mitochondrial quality in a rat model of mitral regurgitation
Subclinical Cardiac Dysfunction in Rheumatoid Arthritis
ALDH2 mitigates LPS-induced cardiac dysfunction, inflammation, and apoptosis through the cGAS/STING pathway
Cardiac-specific overexpression of Ndufs1 ameliorates cardiac dysfunction after myocardial infarction by alleviating mitochondrial dysfunction and apoptosis
Extracorporeal life support in pediatric cardiac dysfunction
JDP2 overexpression provokes cardiac dysfunction in mice
Zyxin protects from hypertension-induced cardiac dysfunction
UCP3 Ablation Exacerbates High-Salt Induced Cardiac Hypertrophy and Cardiac Dysfunction
Inhibition of the cardiac fibroblast-enriched histone methyltransferase Dot1L prevents cardiac fibrosis and cardiac dysfunction
Caffeic acid ethanolamide prevents cardiac dysfunction through sirtuin dependent cardiac bioenergetics preservation
Lipoxin A4 improves cardiac remodeling and function in diabetes-associated cardiac dysfunction